Trial · NCT01687413
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Disease-free Survival (DFS) | 1 year | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Locoregional Control | Up to 2 years | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Rate of Distant Metastasis | Up to 2 years | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Disease Specific Survival | 1 year | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Complications/Acute Toxicity by Organ Class | Approximately 18 weeks | One participant in each Arm did not have adverse events collected. | number of adverse events | NUMBER |
| SECONDARY | Change in Quality of Life as Measured by the MD Anderson Dysphagia Inventory | Baseline, 1 month, 6 months, 12 months, and 24 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Cognitive Function as Measured by Cognitive Failures Questionnaire | Baseline, 1 month, 12 months, and 24 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life as Measured by Neck Dissection Impairment Index (NDII) | Baseline, 12 months, and 24 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life as Measured by University of Michigan Xerostomia Questionnaire | Baseline, 1 month, 6 months, 12 months, and 24 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Hearing as Measured by Hearing Handicap Inventory - Adult | Baseline, 1 month, and 12 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life as Measured by Scale of Subjective Total Taste Acuity | Baseline, 1 month, 6 months, and 12 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life as Measured by Speech Handicap Index | Baseline and 12 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life as Measured by EORTC QLQ-C30 | Baseline, 1 month, 6 months, 12 months, and 24 months | Some participants were not analyzed as the participants did not complete the questionnaires. | score on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01687413/outcomes